Dextro propoxyphene hydrochloride,* first synthesized by Sullivan and Pohland,1 has been shown to elevate pain threshold significantly without toxic effects or withdrawal symptoms. In a study of patients with chronic pain, Gruber demonstrated that dextro propoxyphene produced an analgesic effect similar to that produced by an equivalent amount of orally administered codeine phosphate.2 Side-effects and complications following dextro propoxyphene administration have been few and mild.
This study was undertaken to determine the relative merits of dextro propoxyphene, 100 mg., meperidine hydrochloride,* 100 mg., and a placebo, when administered orally for the relief of postoperative pain. A second objective was to determine whether potent oral analgesics may be substituted for parenterally administered narcotics in the care of selected patients during the early postoperative period.
The analgesic activity of the 3 test drugs was evaluated in 100 postoperative patients. Estimates of pain intensity, as determined by careful interrogation of the
REISS R, AUFSES AH. Dextro Propoxyphene Versus Meperidine: An Evaluation of Analgesic Activity of These Hydrochlorides in Postoperative Patients. Arch Surg. 1961;82(3):429–431. doi:10.1001/archsurg.1961.01300090099020
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: